首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3605篇
  免费   502篇
  国内免费   41篇
耳鼻咽喉   32篇
儿科学   173篇
妇产科学   51篇
基础医学   445篇
口腔科学   56篇
临床医学   489篇
内科学   1072篇
皮肤病学   104篇
神经病学   282篇
特种医学   335篇
外科学   392篇
综合类   67篇
一般理论   4篇
预防医学   232篇
眼科学   33篇
药学   219篇
中国医学   1篇
肿瘤学   161篇
  2024年   13篇
  2023年   58篇
  2022年   25篇
  2021年   56篇
  2020年   115篇
  2019年   41篇
  2018年   119篇
  2017年   102篇
  2016年   111篇
  2015年   100篇
  2014年   143篇
  2013年   183篇
  2012年   166篇
  2011年   126篇
  2010年   129篇
  2009年   153篇
  2008年   124篇
  2007年   134篇
  2006年   121篇
  2005年   129篇
  2004年   106篇
  2003年   110篇
  2002年   95篇
  2001年   87篇
  2000年   77篇
  1999年   81篇
  1998年   107篇
  1997年   115篇
  1996年   99篇
  1995年   85篇
  1994年   71篇
  1993年   77篇
  1992年   80篇
  1991年   57篇
  1990年   68篇
  1989年   89篇
  1988年   80篇
  1987年   66篇
  1986年   51篇
  1985年   54篇
  1984年   38篇
  1983年   22篇
  1982年   22篇
  1981年   17篇
  1980年   24篇
  1979年   20篇
  1978年   20篇
  1977年   19篇
  1976年   19篇
  1975年   13篇
排序方式: 共有4148条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.

Background

One approach to boost influenza vaccination coverage has been to expand immunization authority. In 2012, the province of Ontario gave community pharmacists the authority to administer the influenza vaccine.

Objective

This study investigates the perspectives of Ontario pharmacy patrons, who had not recently received this vaccine from a pharmacist, regarding this pharmacist service.

Methods

A survey was administered in six Ontario community pharmacies to pharmacy patrons who had not received an influenza vaccination from a pharmacist during the previous year. The instrument included questions about influenza vaccination, and knowledge of and attitudes toward vaccines and pharmacist-administered immunization.

Results

A total of 541 pharmacy patrons completed the survey (53.9% response rate). About one-third (30.5%) of respondents were not aware that pharmacists could give the influenza vaccine, with younger individuals being less likely to be aware (OR 0.48, 95% CI 0.29–0.77, p?<?0.05) and less likely to receive the vaccine annually (OR 0.28, 95% CI 0.19–0.42, p?<?0.05). Leading reasons respondents gave as to why they did not receive their influenza vaccine from a pharmacist included not wanting or feeling they needed to be immunized (41.6%) and being used to receiving the vaccine from a physician (16.5%). Concerns about the experience and training of pharmacists and lack of privacy in a community pharmacy were uncommon.

Conclusion

Reduced awareness of the availability of pharmacist-provided influenza vaccine is still common. Pharmacists have a significant opportunity to address lack of awareness and vaccine hesitancy issues. They can promote this service to increase influenza vaccination rates among pharmacy patrons who do not utilize this professional service.  相似文献   
5.
6.
7.
8.
9.
We studied the pharmacokinetics of intravenously and orally administered lamivudine at six dose levels ranging from 0.5 to 10 mg/kg of body weight in 52 children with human immunodeficiency virus infection. A two-compartment model with first-order elimination from the central compartment was simultaneously fitted to the serum drug concentration-time data obtained after intravenous and oral administration. The maximal concentration at the end of the 1-h intravenous infusion and the area under the concentration-time curve after oral and intravenous administration increased proportionally with the dose. The mean clearance of lamivudine (± standard deviation) in the children was 0.53 ± 0.19 liter/kg/h (229 ± 77 ml/min/m2 of body surface area), and the mean half-lives at the distribution and elimination phases were 0.23 ± 0.18 and 2.2 ± 2.1 h, respectively. Clearance was age dependent when normalized to body weight but age independent when normalized to body surface area. Lamivudine was rapidly absorbed after oral administration, and 66% ± 25% of the oral dose was absorbed. Serum lamivudine concentrations were maintained above 1 μM for ≥8 h of 24 h on the twice daily oral dosing schedule with doses of ≥2 mg/kg. The cerebrospinal fluid drug concentration measured 2 to 4 h after the dose was 12% (range, 0 to 46%) of the simultaneously measured serum drug concentration. A limited-sampling strategy was developed to estimate the area under the concentration-time curve for concentrations in serum at 2 and 6 h.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号